Article | June 29, 2016

Selecting The Optimal Resins For mAb Process Purification

Source: Bio-Rad Laboratories, Inc.
Contact The Supplier
Bio-rad

By Payal Khandelwal, PhD

Determine Your Optimal mAb Purification Strategy with Our Broad Range of Resins
The development of monoclonal antibody (mAb) technology over the past 25 years has fundamentally changed the questions we ask and led to many innovative discoveries. These highly specific biological products have significantly influenced the direction and progress of research and therapeutics. In research, mAbs are primarily produced and used to isolate, identify, and characterize a specific protein. On the therapeutic front, they have shown promise in treating diseases such as cancer, chronic inflammation, and infection. These applications make mAb purification one of the largest and fastest growing areas of the pharmaceutical industry.